HemaCare provides a variety of primary human cells and blood components collected from IRB consented normal donors and patients derived from the following tissues:
Human cells and tissue are critical raw materials for cell therapy and tissue-engineered products, as well as ex vivo gene therapy products, but often introduce significant variability. Rigorous operational controls, quality systems, and analytical capabilities enable optimal, consistent cell collection, a critical factor for successful research and development of novel cell-based products and technology. Researchers chose HemaCare to be their provider of choice for customized, high-quality, consistent, human primary cells, blood components, and tissues. HemaCare controls procedures and collection sites under a formal quality system, with GMP-compliant, validated procedures and equipment, and ability to perform GTP-compliant donor screening, allowing you to experience increased experimental consistency due to predictable high yield cell collections.
Healthy cells and blood components are collected in HemaCare's owned and operated FDA-registered, AABB-accredited collection center. Diseased products are collected through our cooperative working relationships with various clinics and hospitals around the country. All primary human cells and blood components are processed, isolated, and cultured in our laboratory using our state-of-the art equipment. Our laboratory is managed by highly trained scientists to provide you with quality, consistent, viable primary cells and blood components.